India 
USA
UK
South Africa
Australia
Philippines
Germany
Netherlands
Mexico
Brazil
Canada
-
August 4, 2023
Vinita Gupta, CEO, Nilesh Gupta, MD and Ramesh Swaminathan, ED, Global CFO and Head Corporate Affairs, Lupin, with ET Now on the Q1 FY2024 Earnings
-
July 18, 2023
Lupin Digital Health leveraging AI/ML to reduce heart attack risks – Siddharth Srinivasan’s article published in BizzBuzz.
-
June 28, 2023
Can the Gupta siblings solve Lupin’s US puzzle? – Vinita Gupta and Nilesh Gupta’s interview in the Livemint .
-
June 28, 2023
Mr. Ramesh Swaminathan on ET Now on the Spiriva approval
-
June 28, 2023
Sreeji Gopinathan’s interview in the Business Today magazine on ‘Lupin undergoing significant tech adoption, upgrade..’.
-
June 22, 2023
Nilesh Gupta on CNBC TV18 regarding the Spiriva approval
-
June 22, 2023
Ramesh Swaminathan, ED, Global CFO and Head Corporate Affairs on CNBC TV18 on the Spiriva approval
-
June 19, 2023
India’s biosimilars industry staring at plethora of opportunities – Dr Cyrus Karkaria’s article in the Bio Voice .
-
June 6, 2023
Regulatory scrutiny and pricing pressure is reducing profitability – Ramesh Swaminathan, Executive Director, Global CFO, and Head Corporate Affairs, Lupin in an Industry Story, Published in Fortune India.
